Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry

Launched by BAXTER HEALTHCARE CORPORATION · Oct 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective a specific type of kidney treatment called continuous renal replacement therapy (CRRT) is for children weighing between 8 and 20 kilograms (about 17.6 to 44.1 pounds) who are suffering from acute kidney injury (AKI), acute renal failure (ARF), or fluid overload. Researchers will look at data from children treated with the HF20 set of equipment and compare it with data from a similar group of children who were treated with a different type of equipment called the M60 set. The goal is to understand which treatment works better for these young patients.

To be eligible for this study, children must weigh between 8 and 20 kg, have been treated in an intensive care unit (ICU), and have a diagnosis of AKI, ARF, or fluid overload that required CRRT. There are no exclusions based on other health conditions, so if your child meets these weight and treatment criteria, they could participate. Families can expect that their child's data will be collected and analyzed to help improve future treatments for kids with similar conditions. This research is important because it could lead to better kidney care for children in critical situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient weighed between 8 and 20 kg (17.6 - 44.1 lb).
• • 2. Patient received medical care in an intensive care unit (ICU) and was treated with HF20 based CRRT.
• • 3. Patient had a clinical diagnosis of AKI or ARF or fluid overload requiring CRRT.
• • Note: The cohort of patients treated with M60 sets from the ppCRRT registry (weighing 8 - 20 kg) are to meet inclusion criteria 1 and 3.
• Exclusion Criteria:
• • There are no exclusion criteria for this study.